CMMB → $5.00 by Nov 6, 2026.

Heya Here is some DD for you. July 8 - Scipher Medicine, American private precision medicine and AI company, and Chemomab, Israeli clinical stage biotech company, announced merger definitive agreement between the two. They will combine to become one company, Scipher Medicine, and will relist on Nasdaq under a different ticker than "$CMMB" which Chemomab lists as today. And the company will become a US company. Here comes the juicy part: The combined value of the company will be $150M. …